Newton, MA (PRWEB) April 08, 2014
TrialNetworks and its Clinical Trial Optimization System won the Disruptive Innovator and Technology of the Year award from Partnerships in Clinical Trials 2014. The award was announced on the final day of the premier industry conference held in Las Vegas, NV. The award honors an individual or a company with a new disruptive technology platform that has increased the efficiency and quality of clinical trials. TrialNetworks technology is used by companies including Merck & Co., Biogen Idec, ARIAD Pharmaceuticals and Infinity Pharmaceuticals to optimize clinical operations from startup through closeout.
Megan Knapp, Managing Director of the Pharmaceutical and Healthcare Division at conference organizer IIR USA, said, “Our expert Partnerships Advisory Board comprised of more than 30 expert clinical research leaders chose the TrialNetworks Clinical Trial Optimization System as the 2014 winner from a field of strong finalists. According to customers and users experienced with the platform, TrialNetworks is breaking significant new ground in enabling sponsors, CROs and sites to optimize clinical operations through efficient collaboration and process improvement. We applaud TrialNetworks for this accomplishment and look forward to new achievements from this innovative company.”
TrialNetworks Co-Founder and CEO Eric Silberstein said, “We’re grateful and thrilled for this recognition not only for everyone at TrialNetworks, but also for our customers. Our customers guide us in developing novel technology-powered approaches to solving important problems in clinical operations. As a company, we are passionate about creating a unified platform of modern solutions to eliminate inefficiencies, ensure quality and make life easier for sites.”
Request a demo to learn what makes TrialNetworks a disruptive innovation in clinical operations.
TrialNetworks – winner of the 2014 Disruptive Innovator and Technology of the Year award from Partnerships in Clinical Trials – provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using this modern and intuitive technology, customers such as Merck & Co., Biogen Idec and Infinity Pharmaceuticals are able to transform the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist™, Training™, Document Library™, Visit Guide™, Action Items™ and Directory™, are available in a unified and secure cloud-based interface. Customers ranging from biotechs to Top-10 pharma companies have implemented the TrialNetworks platform for use in Phase I-IV trials by more than 25,000 site staff in 60 countries. To learn why sponsors and CROs rely on TrialNetworks to optimize clinical trial operations, request a guided online demo at http://www.trialnetworks.com.